Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinib
BJU International  (IF5.588),  Pub Date : 2021-09-22, DOI: 10.1111/bju.15600
Sarah J. Welsh, Nicola Thompson, Anne Warren, Andrew N. Priest, Tristan Barrett, Stephan Ursprung, Ferdia A. Gallagher, Fulvio Zaccagna, Grant D. Stewart, Kate M. Fife, Athena Matakidou, Andrea J. Machin, Wendi Qian, Victoria Ingleson, Jean Mullin, Antony C. P. Riddick, James N. Armitage, Stephen Connolly, Timothy G. Q. Eisen

To explore translational biological and imaging biomarkers for sunitinib treatment before and after debulking nephrectomy in the NeoSun (European Union Drug Regulating Authorities Clinical Trials Database [EudraCT] number: 2005-004502-82) single-centre, single-arm, single-agent, Phase II trial.